Genetic variants in the metabolism of omega-6 and omega-3 fatty acids: Their role in the determination of nutritional requirements and chronic disease risk

Experimental Biology and Medicine

Volumn 235, Issue 7, 2010, Pages 785-795

  Simopoulos, Artemis P ^a  

^a Center for Nutrition Genetics & Health   (United States)

Author keywords

5 Lipoxygenase; Cancer; Coronary heart disease; Cyclooxygenase 2; FADS1 and FADS2 polymorphisms; Inflammation; Lactation; Nutrigenetics; Nutrigenomics; Obesity; Pregnancy; PUFA and LC PUFA; Upregulation and downregulation of gene expression

Indexed keywords

ACYL COENZYME A DESATURASE 1; ARACHIDONATE 5 LIPOXYGENASE; CYCLOOXYGENASE 2; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; LINOLEIC ACID; LINOLEOYL COENZYME A DESATURASE; LONG CHAIN FATTY ACID; MEMBRANE PHOSPHOLIPID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PLASMINOGEN ACTIVATOR INHIBITOR 1; POLYUNSATURATED FATTY ACID; TUMOR NECROSIS FACTOR ALPHA;

ACUTE HEART INFARCTION; ANTIINFLAMMATORY ACTIVITY; ATHEROSCLEROSIS; BREAST CANCER; BREAST FEEDING; BREAST MILK; CANCER RISK; CARDIOVASCULAR RISK; CHRONIC DISEASE; CLINICAL TRIAL; COMPETITIVE INHIBITION; DIET SUPPLEMENTATION; DIETARY INTAKE; DISEASE ASSOCIATION; DOWN REGULATION; ENVIRONMENTAL EXPOSURE; FATTY ACID METABOLISM; GENE CLUSTER; GENE EXPRESSION; GENETIC VARIABILITY; GENOME ANALYSIS; GENOTYPE; HUMAN; INFLAMMATION; INTELLIGENCE QUOTIENT; ISCHEMIC HEART DISEASE; LACTATION; LIPID COMPOSITION; LOW DRUG DOSE; MATERNAL NUTRITION; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; NUTRIGENOMICS; NUTRITIONAL REQUIREMENT; OBESITY; PHOSPHOLIPID BLOOD LEVEL; PREGNANCY; PROSTATE CANCER; RISK ASSESSMENT; SHORT SURVEY; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ARACHIDONATE 5-LIPOXYGENASE; BREAST NEOPLASMS; CHILD; CORONARY DISEASE; CYCLOOXYGENASE 2; FATTY ACID DESATURASES; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; FEMALE; GENE EXPRESSION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFLAMMATION; INTELLIGENCE; LACTATION; MALE; NUTRIGENOMICS; NUTRITIONAL REQUIREMENTS; OBESITY; POLYMORPHISM, GENETIC; PREGNANCY; PROSTATIC NEOPLASMS;

EID: 77953742101     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1258/ebm.2010.009298     Document Type: Short Survey

References (107)

1. Burr GO, Burr MM. On the nature and role of fatty acids essential in nutrition. J Biol Chem 1930;86:587-622
2. Simopoulos AP. The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Exp Biol Med (Maywood) 2008;233:674-88
3. Simopoulos AP. Omega-3 fatty acids in health and disease and in growth and development. Am J Clin Nutr 1991;54:438-63
4. Simopoulos AP, Norman HA, Gillaspy JE, Duke JA. Common purslane: a source of omega-3 fatty acids and antioxidants. J Am Coll Nutr 1992;11:374-82
5. Simopoulos AP. Omega-6/omega-3 essential fatty acids: biological effects. In: Simopoulos AP, Bazan NG, eds. Omega-3 Fatty Acids, the Brain and Retina. World Rev Nutr Diet Vol. 99. Basel: Karger, 2009:1-16
6. Burdge G. Alpha-linolenic acid metabolism in men and women: nutritional and biological implications. Curr Opin Clin Nutri Metab Care 2004;7:137-44 (Pubitemid 40340675)
7. Cho HP, Nakamura MT, Clarke SD. Cloning, expression, and nutritional regulation of the mammalian delta-6 desaturase. J Biol Chem 1999;274:471-7
8. Cho HP, Nakamura M, Clarke SD. Cloning, expression, and fatty acid regulation of the human delta-5 desaturase. J Biol Chem 1999;274:37335-9 (Pubitemid 30016815)
9. Weber PC, Fischer S, von Schacky C, Lorenz R, Strasser T. Dietary omega-3 polyunsaturated fatty acids and eicosanoid formation in man. In: Simopoulos AP, Kifer RR, Martin RE, eds. Health Effects of Polyunsaturated Fatty Acids in Seafoods. Orlando: Academic Press, 1986:49-60
10. Lewis RA, Lee TH, Austen KF. Effects of omega-3 fatty acids on the generation of products of the 5-lipoxygenase pathway. In: Simopoulos AP, Kifer RR, Martin RE, eds. Health Effects of Polyunsaturated Fatty Acids in Seafoods. Orlando: Academic Press, 1986:227-38
11. Burr ML, Fehily AM, Gilbert JF, Rogers S, Holliday RM, Sweetnam PM, Elwood PC, Deadman NM. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet 1989;2:757-61 (Pubitemid 19234807)
12. Leaf A. Cardiovascular effects of fish oils. Beyond the platelet. Circulation 1990;82:624-8
13. Leaf A, Weber PC. Cardiovascular effects of n-3 fatty acids. N Engl J Med 1988;318:549-57 (Pubitemid 18083576)
14. Simopoulos AP, Kifer RR, Martin RE, eds. Health Effects of Polyunsaturated Fatty Acids in Seafoods. Orlando: Academic Press, 1986
15. Simopoulos AP, Kifer RR, Martin RE, Barlow SM, eds. Health Effects of w3 Polyunsaturated Fatty Acids in Seafoods. World Rev Nutr Diet Vol. 66. Basel: Karger, 1991
16. Von Schacky C. Prophylaxis of atherosclerosis with marine omega-3 fatty acids: a comprehensive strategy. Ann Intern Med 1988;107:890-9 (Pubitemid 18014243)
17. Innis SM. Essential fatty acids in growth and development. Prog Lipid Res 1991;30:39-103
18. Cha YI, Solnica-Krezel L, DuBois RN. Fishing for prostanoids: deciphering the developmental functions of cyclooxygenase-derived prostaglandins. Dev Biol 2006;289:263-72 (Pubitemid 43049931)
19. Harizi H, Gualde N. The impact of eicosanoids on the crosstalk between innate and adaptive immunity: the key role of dendritic cells. Tissue Antigens 2005;65:507-14 (Pubitemid 40776298)
20. Leu BH, Schmidt JT. Arachidonic acid as a retrograde signal controlling growth and dynamics of retinotectal arbors. Dev Neurobiol 2008;68:18-30
21. Khanapure SP, Garvey DS, Janero DR, Letts LG. Eicosanoids in inflammation: biosynthesis, pharmacology and therapeutic frontiers. Curr Top Med Chem 2007;7:311-40
22. Peskar BM, Sawka N, Ehrlich K, Peskar BA. Role of cyclooxygenase-1 and -2, phospholipase C, and protein kinase C in prostaglandin mediated gastroprotection. J Pharmacol Exp Ther 2003;305:1233-8 (Pubitemid 36618003)
23. Simopoulos AP, Bazan NG, eds. Omega-3 Fatty Acids, the Brain and Retina. World Rev Nutr Diet Vol. 99. Basel: Karger, 2009
24. Serhan CN, Chiang N, Van Dyke TE. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol 2008;8:349-61 (Pubitemid 351595216)
25. Koletzko B, Demmelmair H, Schaeffer L, Illig T, Heinrich J. Genetically determined variation in polyunsaturated fatty acid metabolism may result in different dietary requirements. Nestle Nutr Workshop Ser Pediatr Program 2008;62:35-44; discussion 44-9
26. Schaeffer L, Gohlke H, Muller M, Heid IM, Palmer LJ, Kompauer I, Demmelmair H, Illig T, Koletzko B, Heinrich J. Common genetic variants of the FADS1 FADS2 gene cluster and their reconstructed haplotypes are associated with the fatty acid composition in phospholipids. Hum Mol Genet 2006;15:1745-56 (Pubitemid 43821765)
27. Xie L, Innis SM. Genetic variants of the FADS1 FADS2 gene cluster are associated with altered (n-6) and (n-3) essential fatty acids in plasma and erythrocyte phospholipids in women during pregnancy and in breast milk during lactation. J Nutr 2008;138:2222-8
28. Caspi A, Williams B, Kim-Cohen J, Craig IW, Milne BJ, Poulton R, Schalkwyk LC, Taylor A, Werts H, Moffitt TE. Moderation of breastfeeding effects on the IQ by genetic variation in fatty acid metabolism. Proc Natl Acad Sci 2007;104:18860-5 (Pubitemid 350210787)
29. Martinelli N, Girelli D,Malerba G, Guarini P, Illig T, Trabetti E, Sandri M, Friso S, Pizzolo F, Schaeffer L, Heinrich J, Pignatti PF, Corrocher R, Olivieri O. FADS genotypes and desaturase activity estimated by the ratio of arachidonic acid to linoleic acid are associated with inflammation and coronary artery disease. Am J Clin Nutr 2008;88:941-9
30. Allayee H, Baylin A, Hartiala J, Wijesuriya H, Mehrabian M, Lusis AJ, Campos H. Nutrigenetic association of the 5-lipoxygenase gene with myocardial infarction. Am J Clin Nutr 2008;88:934-40
31. Fradet V, Cheng I, Casey G, Witte JS. Dietary omega-3 fattyacids, cyclooxygenase-2 geneticvariation, and aggressive prostate cancer risk. Clin Cancer Res 2009;15:2559-66
32. Simopoulos AP, Ordovas JM, eds. Nutrigenetics and Nutrigenomics. World Rev Nutr Diet Vol. 93. Basel: Karger, 2004
33. Simopoulos AP, Childs B, eds. Genetic Variation and Nutrition. World Rev Nutr Diet Vol. 63. Basel: Karger, 1990
34. Bonne-Tamir B, Adam A. Genetic Diversity Among Jews: Diseases and Markers at the DNA Level. New York: Oxford University Press, 1992
35. Bowman JE, Murray RF. Genetic Variation and Disorders in Peoples of African Origin. Baltimore: Johns Hopkins University Press, 1990
36. Gonzalez FJ, Skoda RC, Kimura S, Umeno M, Zanger UM, Nebert DW, Gelboin HV, Hardwick JP, Meyer UA. Characterization of the common genetic defect in humans deficient in debrisoquine metabolism. Nature 1988;331:442-6 (Pubitemid 18064368)
37. Kalow W, Goedde HW, Agarwal DP, eds. Ethnic Differences in Reactions to Drugs and Xenobiotics. New York: Liss, 1986:491
38. Evans DA, Harmer D, Downham DY, Whibley EJ, Idle JR, Ritchie J, Smith RL. The genetic control of sparteine and debrisoquine in metabolism in man with new methods of analyzing biomodal distributions. J Med Genet 1983;20:321-9 (Pubitemid 13002788)
39. Idle JR. Poor metabolizers of debrisoquine reveal their true colours. Lancet 1989;2:1097
40. Wolf CR, Moss JE, Miles JS, Gough AC, Spurr NK. Detection of debrisoquine hydroxylation phenotypes. Lancet 1990;336:1452-3
41. Sladek R, Rocheleau G, Rung J, Dina C, Shen L, Serre D, Boutin P, Vincent D, Belisle A, Hadjadj S, Balkau B, Heude B, Charpentier G, Hudson TJ, Montpetit A, Pshezhetsky AV, Prentki M, Posner BI, Balding DJ, Meyre D, Polychronakos C, Froguel P. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 2007;445:881-5
42. Amundadottir LT, Sulem P, Gudmundsson J, Helgason A, Baker A, Agnarsson BA, Sigurdsson A, Benediktsdottir KR, Cazier JB, Sainz J, Jakobsdottir M, Kostic J, Magnusdottir DN, Ghosh S, Agnarsson K, Birgisdottir B, Le Roux L, Olafsdottir A, Blondal T, Andresdottir M, Gretarsdottir OS, Bergthorsson JT, Gudbjartsson D, Gylfason A, Thorleifsson G, Manolescu A, Kristjansson K, Geirsson G, Isaksson H, Douglas J, Johansson JE, Bäter K, Wiklund F, Montie JE, Yu X, Suarez BK, Ober C, Cooney KA, Gronberg H, Catalona WJ, Einarsson GV, Barkardottir RB, Gulcher JR, Kong A, Thorsteinsdottir U, Stefansson K. A common variant associated with prostate cancer in European and African populations. Nat Genet 2006;38:652-8
43. Graham RR, Kozyrev SV, Baechler EC, Reddy MV, Plenge RM, Bauer JW, Ortmann WA, Koeuth T, González Escribano MF; Argentine and Spanish Collaborative Groups, Pons-Estel B, Petri M, Daly M, Gregersen PK, Martín J, Altshuler D, Behrens TW, Alarcón-Riquelme ME. A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus. Nat Genet 2006;38:550-5
44. Klein RJ, Zeiss C, Chew EY, Tsai JY, Sackler RS, Haynes C, Henning AK, SanGiovanni JP, Mane SM, Mayne ST, Bracken MB, Ferris FL, Ott J, Barnstable C, Hoh J. Complement factor H polymorphism in age related macular degeneration. Science 2005;308:385-9
45. Kyndt F, Probst V, Potet F, Demolombe S, Chevallier JC, Baro I, Moisan JP, Boisseau P, Schott JJ, Escande D, Le Marec H. Novel SCN5A mutation leading either to isolated cardiac conduction defect or Brugada syndrome in a large French family. Circulation 2001;104:3081-6
46. McPherson R, Pertsemlidis A, Kavaslar N, Stewart A, Roberts R, Cox DR, Hinds DA, Pennacchio LA, Tybjaerg-Hansen A, Folsom AR, Boerwinkle E, Hobbs HH, Cohen JC. A common allele on chromosome 9 associated with coronary heart disease. Science 2007;316:1488-91 (Pubitemid 350287153)
47. Simopoulos AP, Herbert V, Jacobson B. The Healing Diet. New York: Macmillan, 1995
48. Simopoulos AP. Nutrition policies for the prevention of atherosclerosis in industrialized societies. In: Moyal MF, ed. Diet and Life Style: New Technology. Paris: Libby, 1988:373-80
49. Koletzko B, Mrotzek M, Bremer HJ. Fatty acid composition of mature human milk in Germany. Am J Clin Nutr 1988;47:954-9
50. Guerra A, Demmelmair H, Toschke AM, Koletzko B. Three-year tracking of fatty acid composition of plasma phospholipids in healthy children. Ann NutI' Metab 2007;51:433-8 (Pubitemid 350212733)
51. Del Prado M, Villalpando S, Elizondo A, Rodríguez M, Demmelmair H, Koletzko B. Contribution of dietary and newly formed arachidonic acid to human milk lipids in women eating a low fat diet. Am J Clin Nutr 2001;74:242-7 (Pubitemid 32702492)
52. Demmelmair H, von Schenck U, Behrendt E, Sauerwald T, Koletzko B. Estimation of arachidonic acid synthesis in full term neonates using natural variation of 13C content. J Pediatr Gastroenterol Nutr 1995;21:31-6
53. Marquardt A, Stohr H, White K, Weber BH. Cdna cloning, genomic structure, and chromosomal localization of three, members of the human fatty acid desaturase family. Genomics 2000;66:175-83 (Pubitemid 30429752)
54. Daniels SE, Bhattacharrya S, James A, Leaves NI, Young A, Hill MR, Faux JA, Ryan GF, le Söuef PN, Lathrop GM, Musk AW, Cookson WO. A genome-wide search for quantitative trait loci underlying asthma. Nature 1996;383:247-50 (Pubitemid 26317671)
55. Institute of Medicine. Infant Formula: Evaluating the Safety of New Ingredients. Washington, DC: National Academies Press, 2004
56. Heird WC, Lapillonne A. The role of essential fatty acids in development. Annu Rev Nutr 2005;25:549-71
57. Farquharson J, Cockburn F, Patrick WA, Jamieson EC, Logan RW. The role of essential fatty acids in development. Lancet 1992;340:810-3
58. Makrides M, Neumann MA, Byard RW, Simmer K, Gibson RA. Fatty acid composition of brain, retina, and erythrocytes in breast- and formula-fed infants. Am J Clin Nutr 1994;60:189-94 (Pubitemid 24233184)
59. McCann JC, Ames BN. Is docosahexaenoic acid, an n-3 long-chain polyunsaturated fatty acid, required for development of normal brain function? An overview of evidence from cognitive and behavioral tests in humans and animals. Am J Clin Nutr 2005;82:281-95
60. Kanehisa M, Goto S, Hattori M, Aoki-Kinoshita KF, Itoh M, Kawashima S, Katayama T, Araki M, Hirakawa M. From genomics to chemical genomics: new developments in KEGG. Nucleic Acids Res 2006;34:D354-7
61. Nakamura MT, Nara TY. Structure, function, and dietary regulation of delta6, delta5, and delta9 desaturases. Annu Rev Nutr 2004;24:345-76
62. Cohen J. Statistical Power Analysis for the Behavioral Sciences. Hillsdale, NJ: Lawrence Earlbaum Associates, 1988
63. Gottfredson LS. Why g matters: the complexity of everyday life. Intelligence 1997;24:79-132 (Pubitemid 127343318)
64. Karolchik D, Baertsch R, Diekhans M, Furey TS, Hinrichs A, Lu YT, Roskin KM, Schwartz M, Sugnet CW, Thomas DJ, Weber RJ, Haussler D, Kent WJ. The UCSC Genome Browser Database. Nucleic Acids Res 2003;31:51-4
65. Fedorova I, Salem N Jr. Omega-3 fatty acids and rodent behavior. Prostaglandins Leukot Essen Fatty Acids 2006;75:271-89 (Pubitemid 44444990)
66. Plomin R. The genetics of g in human and mouse. Nat Rev Neurosci 2001;2:136-41
67. Malerba G, Schaeffer L, Xumerle L, Klopp N, Trabetti E, Biscuola M, Cavallari U, Galavotti R, Martinelli N, Guarini P, Girelli D, Olivieri O, Corrocher R, Heinrich J, Pignatti PF, Illig T. SNPs of the FADS gene cluster are associated with polyunsaturated fatty acids in a cohort of patients with cardiovascular disease. Lipids 2008;43:289-99
68. Tanaka T, Shen J, Abecasis GR, Kisialiou A, Ordovas JM, Guralnik JM, Singleton A, Bandinelli S, Cherubini A, Arnett D, Tsai MY, Ferrucci L. Genome-wide association study of plasma polyunsaturated fatty acids in the InCHIANTI Study. PLoS Genet 2009;5:e1000338
69. Narce M, Asdrubal P, Delachambre MC, Varicel E, Lagarde M, Poisson JP. Age-related changes in linoleic acid bioconversion by isolated hepatocytes from spontaneously hypertensive and normotensive rats. Mol Cell Biochem 1994;141:9-13 (Pubitemid 24226647)
70. Kark JD, Kaufmann NA, Binka F, Goldberger N, Berry EM. Adipose tissue n-6 fatty acids and acute myocardial infarction in a population consuming a diet high in polyunsaturated fatty acids. Am J Clin Nutr 2003;77:796-802
71. Baylin A, Campos H. Arachidonic acid in adipose tissue is associated with nonfatal acute myocardial infarction in the central valley of Costa Rica. J Nutr 2004;134:3095-9 (Pubitemid 39470090)
72. Dwyer JH, Allayee H, Dwyer KM, Fan J, Wu H, Mar R, Lusis AJ, Mehrabian M. Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis. N Engl J Med 2004;350:29-37 (Pubitemid 38032181)
73. Simopoulos AP. Genetic variation and dietary response: nutrigenetics/ nutrigenomics. Asia Pacific J Clin Nutr 2002;11(S6):S117-28
74. Avis IM, Jett M, Boyle T, Vos MD, Moody T, Treston AM, Martínez A, Mulshine JL. Growth control of lung cancer by interruption of 5-lipoxygenase-mediated growth factor signaling. J Clin Invest 1996;97:806-13 (Pubitemid 26057100)
75. Soumaoro LT, Iida S, Uetake H, Ishiguro M, Takagi Y, Higuchi T, Yasuno M, Enomoto M, Sugihara K. Expression of 5-lipoxygenase in human colorectal cancer. World J Gastroenterol 2006;12:6355-60 (Pubitemid 44712419)
76. Ye YN, Wu WK, Shin VY, Bruce IC, Wong BC, Cho CH. Dual inhibition of 5-LOX and COX-2 suppresses colon cancer formation promoted by cigarette smoke. Carcinogenesis 2005;26:827-34
77. Ghosh J, Myers CE. Arachidonic acid stimulates prostate cancer cell growth: critical role of 5-lipoxygenase. Biochem Biophys Res Commun 1997;235:418-23 (Pubitemid 27313723)
78. Sundaram S, Ghosh J. Expression of 5-oxoETE receptor in prostate cancer cells: critical role in survival. Biochem Biophys Res Commun 2006;339:93-8 (Pubitemid 41697519)
79. Faronato M, Muzzonigro G, Milanese G, Menna C, Bonfigli AR, Catalano A, Procopio A. Increased expression of 5-lipoxygenase is common in clear cell renal cell carcinoma. Histol Histopathol 2007;22:1109-18 (Pubitemid 47470305)
80. Hayashi T, Nishiyama K, Shirahama T. Inhibition of 5-lipoxygenase pathway suppresses the growth of bladder cancer cells. Int J Urol 2006;13:1086-91 (Pubitemid 44125681)
81. Wang J, John EM, Ingles SA. 5-Lipoxygenase and 5-lipoxygenase-activating protein gene polymorphisms, dietary linoleic acid, and risk for breast cancer. Cancer Epidemiol Biomarkers Prev 2008;17:2748-54
82. Hedelin M, Chang ET, Wiklund F, Bellocco R, Klint A, Adolfsson J, Shahedi K, Xu J, Adami HO, Grönberg H, Bälter KA. Association of frequent consumption of fatty fish with prostate cancer risk is modified by COX-2 polymorphism. Int J Cancer 2007;120:398-405
83. Rucker R, Tinker D. The role of nutrition in gene expression. A fertile field for the application of molecular biology. J Nutr 1986;116:177-89
84. Osborn TF, Goldstein JL, Brown MS. 5(-End of HMG-CoA reductase gene contains sequences responsible for cholesterol mediated inhibition of transcription. Cell 1985;42:203-12
85. Clarke SD, Jump DB. Regulation of hepatic gene expression by dietary fats: a unique role for polyunsaturated fatty acids. In: Berdanier DC, Hargrove JL, eds. Nutrition and Gene Expression. Boca Raton: CRC Press, 1993
86. Laird JM, Herrero JF, Garcia de la Rubia P, Cervero F. Analgesic activity of the novel COX-2 preferring NSAID, meloxicam in mono-arthritic rats: central and peripheral components. Inflamm Res 1997;46:203-10
87. Clarke SD, Romsos DR, Leveille GA. Differential effects of dietary methylesters of long chain saturated and polyunsaturated fatty acids on rat liver and adipose tissue lipogenesis. J Nutr 1977;107:1170-80
88. Clarke SD, Armstrong MK, Jump DB. Nutritional control of rat liver fatty acid synthase and S14 mRNA abundance. J Nutr 1990;120:218-24
89. Clarke SD, Jump DB. Polyunsaturated fatty acid regulation of hepatic gene transcription. Lipids 1996;31(Suppl.):7-11
90. Kaminski WE, Jendraschak C, Kiefl R, von Schacky C. Dietary omega-3 fatty acids lower levels of platelet-derived growth factor mRNA in human mononuclear cells. Blood 1993;81:1871-9
91. Robinson DR, Urakaze M, Huang R, Taki H, Sugiyama E, Knoell CT, Xu L, Yeh HT, Auron PE. Dietary marine lipids suppress the continuous expression of interleukin-1B gene transcription. Lipids 1996;31(Suppl.):S23-S31
92. Urakaze M, Sugiyama E, Xu L, Auron P, Yeh E, Robinson D. Dietary marine lipids suppress IL-1B mRNA levels in lipopolysaccharide stimulated monocytes. Clin Res 1991:23
93. Simopoulos AP. The role of fatty acids in gene expression: health implications. Ann Nutr Metab 1996;40:303-11
94. Dahlman I, Linder K, Arvidsson Nordström E, Andersson I, Lidén J, Verdich C, Sørensen TI, Arner P. Changes in adipose tissue gene expression with energy-restricted diets in obese women. Am J Clin Nutr 2005;81:1275-85
95. Crujeiras AB, Parra D, Milagro FI, Goyenechea E, Larrarte E, Margareto J, Martínez JA. Differential expression of oxidative stress and inflammation related genes in peripheral blood mononuclear cells in response to a low-calorie diet: a nutrigenomics study. OMICS 2008;12:251-61
96. Bouwens M, van de Rest O, Dellschaft N, Bromhaar MG, de Groot LC, Geleijnse JM, Müller M, Afman LA. Fish oil supplementation induces anti-inflammatory gene expression profiles in human blood mononuclear cells. Am J Clin Nutr 2009;90:415-24
97. Kabir M, Skurnik G, Naour N, Pechtner V, Meugnier E, Rome S, Quignard-Boulangé A, Vidal H, Slama G, Clément K, Guerre-Millo M, Rizkalla SW. Treatment for 2 mo with n 3 polyunsaturated fatty acids reduces adiposity and some atherogenic factors but does not improve insulin sensitivity in women with type 2 diabetes: a randomized controlled study. Am J Clin Nutr 2007;86:1670-9
98. Garaulet M, Hernandez-Morante JJ, Lujan J, Tebar FJ, Zamora S. Relationship between fat cell size and number and fatty acid composition in adipose tissue from different fat depots in overweight/ obese humans. Int J Obes (Lond) 2006;30:899-905 (Pubitemid 43801188)
99. Micallef M, Munro I, Phang M, Garg M. Plasma n-3 polyunsaturated fatty acids are negatively associated with obesity. Br J Nutr 2009:1-5
100. Couet C, Delarue J, Ritz P, Antoine JM, Lamisse F. Effect of dietary fish oil on body fat mass and basal fat oxidation in healthy adults. Int J Obes Relat Metab Disord 1997;21:637-43
101. Hill AM, Buckley JD, Murphy KJ, Howe PR. Combining fish-oil supplements with regular aerobic exercise improves body composition and cardiovascular disease risk factors. Am J Clin Nutr 2007;85:1267-74
102. Mori TA, Bao DQ, Burke V, Puddey IB, Watts GF, Beilin LJ. Dietary fish as a major component of a weight-loss diet: effect on serum lipids, glucose, and insulin metabolism in overweight hypertensive subjects. Am J Clin Nutr 1999;70:817-25 (Pubitemid 29512906)
103. Clément K, Viguerie N, Poitou C, Carette C, Pelloux V, Curat CA, Sicard A, Rome S, Benis A, Zucker JD, Vidal H, Laville M, Barsh GS, Basdevant A, Stich V, Cancello R, Langin D. Weight loss regulates inflammation-related genes in white adipose tissue of obese subjects. FASEB J 2004;18:1657-69
104. Viguerie N, Poitou C, Cancello R, Stich V, Clement K, Langin D. Transcriptomics applied to obesity and caloric restriction. Biochimie 2005;87:117-23 (Pubitemid 40298774)
105. Lattka E, Illig T, Heinrich J, Koletzko B. FADS gene cluster polymorphisms: important modulators of fatty acid levels and their impact on atopic diseases. J Nutrigenet Nutrigenomics 2009;2:119-28 Epub 2009 Sep 23. Review. PubMed PMID: 19776639
106. Lattka E, Illig T, Heinrich J, Koletzko B. Do FADS genotypes enhance our knowledge about fatty acid related phenotypes? Clin Nutr 2009 Nov 28. Epub ahead of print PubMed PMID: 19948371
107. Lattka E, Illig T, Koletzko B, Heinrich J. Genetic variants of the FADS1 FADS2 gene cluster as related to essential fatty acid metabolism. Curr Opin Lipidol 2009 Oct 3. Epub ahead of print. PubMed PMID: 19809313